Experts predict that physicians may favour emerging biosimilar versions of Stelara over more effective originator IL-23 drugs ...

Choose wisely, experts say, when you pick your Medicare Part D prescription drug plan for 2025. What's in the formulary ...

Cigna surpassed Wall Street estimates for third-quarter profit on Thursday, driven by high demand for biosimilars of a blockbuster arthritis drug and its pharmacy benefit management unit gaining new ...

Thank you for taking time out of your very busy schedule to join the FY ‘24 Q2 earnings announcement by Takeda. I’m the master of ceremony, Head of IR. My name is O’Reilly. Thank you for this ...

Secure Access to Medical Records: Patients can view their health records, including lab results, medication lists, and visit ...

NOT FOR UK USE ? NOT INTENDED FOR UK MEDIA In the first nine months of 2024, LEO Pharma delivered revenue growth of 11% in constant exchange rates (CER). The dermatology portfolio saw revenue growth ...

Q3 2024 Earnings Call Transcript October 31, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - ...

Q3 2024 Earnings Call Transcript October 30, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $3, expectations ...

Good morning, and thank you for standing by. Welcome to the AbbVie third quarter 2024 earnings conference call. (Operator Instructions) Today's call is being recorded. I would now like to introduce Ms ...

As a profit-to-member fund, we’re your biggest supporter.

A research plan is a thoughtful, compelling, well-written document that outlines your exciting, unique research ideas that you and your students will pursue over the next half decade or so to advance ...

THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.